Evaluation of Novel Obesity and Lipid-Related Indices as Indicators for the Diagnosis of Metabolic Syndrome and Premetabolic Syndrome in Chinese Women with Polycystic Ovary Syndrome

Objectives. According to the International Diabetes Federation (IDF) criteria, previous studies in Chinese women with polycystic ovary syndrome (PCOS) reported a low prevalence of metabolic syndrome (MS); however, the same population predisposed to developing pre-MS. Early identification and treatme...

Full description

Saved in:
Bibliographic Details
Main Authors: Qianqian Yin, Jianhua Zheng, Yijuan Cao, Xiaonan Yan, Hong Zhang
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2021/7172388
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850162976896581632
author Qianqian Yin
Jianhua Zheng
Yijuan Cao
Xiaonan Yan
Hong Zhang
author_facet Qianqian Yin
Jianhua Zheng
Yijuan Cao
Xiaonan Yan
Hong Zhang
author_sort Qianqian Yin
collection DOAJ
description Objectives. According to the International Diabetes Federation (IDF) criteria, previous studies in Chinese women with polycystic ovary syndrome (PCOS) reported a low prevalence of metabolic syndrome (MS); however, the same population predisposed to developing pre-MS. Early identification and treatment of individuals with MS and pre-MS are imperative to prevent their adverse consequences. Moreover, fasting plasma glucose (FPG) was not accurate in detecting pathoglycemia in women with PCOS as they have shown characteristically postprandial abnormalities in the carbohydrate metabolism. Therefore, we aimed to compare the discriminative performance of various indices for identifying MS and pre-MS/MS (pre-MS and MS) using the updated Chinese Diabetes Society (uCDS) criteria in Chinese women with PCOS. Methods. 1083 Chinese women with PCOS were included in this study. We measured and evaluated 8 indices in all individuals. Based on the uCDS criteria for MS, patients who had no less than two components of MS but did not meet the criteria for the diagnosis of MS were considered as having pre-MS. Receiver operating characteristic (ROC) curves and the area under ROC curves (AUCs) levels were used to assess the accuracy of each index in detecting MS and pre-MS/MS. Results. Among the 8 indices assessed, the lipid accumulation product (LAP) provided the highest AUCs for detecting MS and pre-MS/MS, followed by CVAI, WTI, VAI, TyG, TG/HDL, WC, and BMI. The optimal cutoff points determined for LAP were 45.13 (sensitivity 88.0%, specificity 88.4%, and Youden index 0.764) for MS and 28.01 (sensitivity 87.5%, specificity 80.7%, and Youden index 0.681) for pre-MS/MS, respectively. Conclusions. uCDS criteria are reasonably more suitable for detecting MS and pre-MS in Chinese women with PCOS. Based on this criterion, LAP is the best index for the diagnosis of MS and pre-MS/MS in Chinese women with PCOS, out of the 8 obesity and lipid-related indices assessed.
format Article
id doaj-art-eefabc2102494c038b6d1ac07cb6f753
institution OA Journals
issn 1687-8337
1687-8345
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-eefabc2102494c038b6d1ac07cb6f7532025-08-20T02:22:25ZengWileyInternational Journal of Endocrinology1687-83371687-83452021-01-01202110.1155/2021/71723887172388Evaluation of Novel Obesity and Lipid-Related Indices as Indicators for the Diagnosis of Metabolic Syndrome and Premetabolic Syndrome in Chinese Women with Polycystic Ovary SyndromeQianqian Yin0Jianhua Zheng1Yijuan Cao2Xiaonan Yan3Hong Zhang4Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Soochow University, No. 1055, Sanxiang Road, Suzhou, Jiangsu 215000, ChinaDepartment of Obstetrics and Gynecology, XuZhou Central Hospital, No. 199, Jiefang Road, Xuzhou, Jiangsu 221009, ChinaCenter for Reproductive Medicine, XuZhou Central Hospital, No. 199, Jiefang Road, Xuzhou, Jiangsu 221009, ChinaCenter for Reproductive Medicine, XuZhou Central Hospital, No. 199, Jiefang Road, Xuzhou, Jiangsu 221009, ChinaDepartment of Obstetrics and Gynecology, The Second Affiliated Hospital of Soochow University, No. 1055, Sanxiang Road, Suzhou, Jiangsu 215000, ChinaObjectives. According to the International Diabetes Federation (IDF) criteria, previous studies in Chinese women with polycystic ovary syndrome (PCOS) reported a low prevalence of metabolic syndrome (MS); however, the same population predisposed to developing pre-MS. Early identification and treatment of individuals with MS and pre-MS are imperative to prevent their adverse consequences. Moreover, fasting plasma glucose (FPG) was not accurate in detecting pathoglycemia in women with PCOS as they have shown characteristically postprandial abnormalities in the carbohydrate metabolism. Therefore, we aimed to compare the discriminative performance of various indices for identifying MS and pre-MS/MS (pre-MS and MS) using the updated Chinese Diabetes Society (uCDS) criteria in Chinese women with PCOS. Methods. 1083 Chinese women with PCOS were included in this study. We measured and evaluated 8 indices in all individuals. Based on the uCDS criteria for MS, patients who had no less than two components of MS but did not meet the criteria for the diagnosis of MS were considered as having pre-MS. Receiver operating characteristic (ROC) curves and the area under ROC curves (AUCs) levels were used to assess the accuracy of each index in detecting MS and pre-MS/MS. Results. Among the 8 indices assessed, the lipid accumulation product (LAP) provided the highest AUCs for detecting MS and pre-MS/MS, followed by CVAI, WTI, VAI, TyG, TG/HDL, WC, and BMI. The optimal cutoff points determined for LAP were 45.13 (sensitivity 88.0%, specificity 88.4%, and Youden index 0.764) for MS and 28.01 (sensitivity 87.5%, specificity 80.7%, and Youden index 0.681) for pre-MS/MS, respectively. Conclusions. uCDS criteria are reasonably more suitable for detecting MS and pre-MS in Chinese women with PCOS. Based on this criterion, LAP is the best index for the diagnosis of MS and pre-MS/MS in Chinese women with PCOS, out of the 8 obesity and lipid-related indices assessed.http://dx.doi.org/10.1155/2021/7172388
spellingShingle Qianqian Yin
Jianhua Zheng
Yijuan Cao
Xiaonan Yan
Hong Zhang
Evaluation of Novel Obesity and Lipid-Related Indices as Indicators for the Diagnosis of Metabolic Syndrome and Premetabolic Syndrome in Chinese Women with Polycystic Ovary Syndrome
International Journal of Endocrinology
title Evaluation of Novel Obesity and Lipid-Related Indices as Indicators for the Diagnosis of Metabolic Syndrome and Premetabolic Syndrome in Chinese Women with Polycystic Ovary Syndrome
title_full Evaluation of Novel Obesity and Lipid-Related Indices as Indicators for the Diagnosis of Metabolic Syndrome and Premetabolic Syndrome in Chinese Women with Polycystic Ovary Syndrome
title_fullStr Evaluation of Novel Obesity and Lipid-Related Indices as Indicators for the Diagnosis of Metabolic Syndrome and Premetabolic Syndrome in Chinese Women with Polycystic Ovary Syndrome
title_full_unstemmed Evaluation of Novel Obesity and Lipid-Related Indices as Indicators for the Diagnosis of Metabolic Syndrome and Premetabolic Syndrome in Chinese Women with Polycystic Ovary Syndrome
title_short Evaluation of Novel Obesity and Lipid-Related Indices as Indicators for the Diagnosis of Metabolic Syndrome and Premetabolic Syndrome in Chinese Women with Polycystic Ovary Syndrome
title_sort evaluation of novel obesity and lipid related indices as indicators for the diagnosis of metabolic syndrome and premetabolic syndrome in chinese women with polycystic ovary syndrome
url http://dx.doi.org/10.1155/2021/7172388
work_keys_str_mv AT qianqianyin evaluationofnovelobesityandlipidrelatedindicesasindicatorsforthediagnosisofmetabolicsyndromeandpremetabolicsyndromeinchinesewomenwithpolycysticovarysyndrome
AT jianhuazheng evaluationofnovelobesityandlipidrelatedindicesasindicatorsforthediagnosisofmetabolicsyndromeandpremetabolicsyndromeinchinesewomenwithpolycysticovarysyndrome
AT yijuancao evaluationofnovelobesityandlipidrelatedindicesasindicatorsforthediagnosisofmetabolicsyndromeandpremetabolicsyndromeinchinesewomenwithpolycysticovarysyndrome
AT xiaonanyan evaluationofnovelobesityandlipidrelatedindicesasindicatorsforthediagnosisofmetabolicsyndromeandpremetabolicsyndromeinchinesewomenwithpolycysticovarysyndrome
AT hongzhang evaluationofnovelobesityandlipidrelatedindicesasindicatorsforthediagnosisofmetabolicsyndromeandpremetabolicsyndromeinchinesewomenwithpolycysticovarysyndrome